Biocon surges on getting EIR with VAI status for Biocon Generics Inc facility

19 Dec 2025 Evaluate

Biocon is currently trading at Rs. 398.50, up by 6.35 points or 1.62% from its previous closing of Rs. 392.15 on the BSE.

The scrip opened at Rs. 393.50 and has touched a high and low of Rs. 401.55 and Rs. 393.50 respectively. So far 44038 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 424.95 on 18-Nov-2025 and a 52 week low of Rs. 290.80 on 03-Mar-2025.

Last one week high and low of the scrip stood at Rs. 401.55 and Rs. 383.70 respectively. The current market cap of the company is Rs. 53344.85 crore.

The promoters holding in the company stood at 54.45%, while Institutions and Non-Institutions held 28.71% and 16.83% respectively.

Biocon has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. Food and Drug Administration (USFDA), for its Biocon Generics Inc facility, located in Cranbury, New Jersey, U.S.

This is based on a cGMP inspection conducted by the agency between the October 6 to October 10, 2025.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

398.35 6.20 (1.58%)
19-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.10
Dr. Reddys Lab 1278.90
Cipla 1517.00
Zydus Lifesciences 919.85
Lupin 2125.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×